A new study by researchers at the University of Michigan and Johns Hopkins University suggests that a relatively small amount of medical data could be compromised in order to help the pharmaceutical industry generate profits.

The study’s results, published online in the Journal of Medical Analytics, show that the information contained in medical records could be potentially manipulated to increase the value of the companies’ drugs and other medical devices.

“We found that the data we were able to collect contained information that could be used to generate profit and other information that would be of interest to the pharmaceutical companies,” said researcher Michael DeCarlo, a Ph.

D. candidate at the UM College of Medicine.

“If the information is used to improve the product, then that would make it more attractive to the market.”

DeCarlo and colleagues used data from more than 20,000 medical records from medical centers in the United States.

They found that some of the records were compromised in a way that could have allowed pharmaceutical companies to profit by selling new medical products that did not match the company’s existing clinical trials.

The researchers analyzed the records of more than 3,000 patients and found that, in some cases, information from the records was modified to generate a false positive for a new drug.

This could result in the company selling more drugs than its competitors.

The problem is not limited to the records themselves.

The researchers found that records containing information about a specific drug or device that had not been evaluated by the company or its partners could be altered to boost the value.

This type of manipulation can happen even if the drug or devices are used in an unapproved way.

The drugs could be added to a class of drugs that may be unsafe or have potential side effects.

This information could be collected about patients who may not have a valid prescription.

The research was done using an open source medical records repository called PatientTracker, a platform that allows users to search for medical records in the medical record system.

The database contains more than 5.7 million medical records, but the researchers found only a small number of records that contain information about drugs or devices.

PatientTracker, which is available to anyone who wants to participate in the research, has about 100 million records, and the researchers are hoping that the platform can provide them with more.

“The potential for a pharmaceutical company to make money from these records is pretty small, but there’s a lot of information in there that could potentially be used,” DeCarlos said.

“In order to make sure the information that we have is accurate, we need to be careful that we don’t compromise the data.”

DeCelo said that there are a number of things that a company can do to improve its records in order for them to remain in the system.

They can add more doctors to review their records.

They could make a correction to the information, such as adding doctors who have been on the team for a longer time, or adding people who have died.

PatientsTracker is available free of charge on the platform, and users can view their own records.

The team is also working on creating a tool that allows patients to search and download the medical records they want.

DeCarlos hopes that PatientTracker can be used for similar research in other fields.

“I think this can be useful for other industries,” DeCelo told The Washington Post.

“We can use it to create a platform to make these data available to other people and researchers in a similar way.”